Bedaquiline susceptibility test for totally drug-resistant tuberculosis Mycobacterium tuberculosis

被引：0

作者：

Ji-Chan Jang

Yong-Gyun Jung

Jungil Choi

Hyunju Jung

Sungweon Ryoo

机构：

[1] Gyeongsang National University,Molecular Mechanisms of Antibiotics, Division of Life Science

[2] Gyeongsang National University,Research Institute of Life Sciences

[3] Myongji University,Interdisciplinary Program of Biomodulation, College of Natural Science

[4] Myongji University,Myongji Bioefficiency Research Centre

[5] Myongji University,Center for Nutraceutical and Pharmaceutical Materials

[6] Northwestern University,Department of Materials Science and Engineering

[7] Korean Institute of Tuberculosis,undefined

[8] Korean National Tuberculosis Association,undefined

来源：

Journal of Microbiology | 2017年 / 55卷

关键词：

bedaquiline; totally drug resistant ;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

This study aimed to provide information that bedaquilline is significantly effective for treatment of totally drug resistant (TDR) Mycobacterium tuberculosis that shows resistant to all first- and second-line drugs-using an innovative disc agarose channel (DAC) system. Time-lapse images of single bacterial cells under culture conditions with different concentrations of bedaquiline were analysed by image processing software to determine minimum inhibitory concentrations (MICs). Bedaquiline inhibited the growth of TDR M. tuberculosis strains, with MIC values ranging from 0.125 to 0.5 mg/L. The results of the present study demonstrate that bedaquiline, newly approved by the United States Food and Drug Administration (FDA), may offer therapeutic solutions for TDR-TB.

引用

页码：483 / 487

页数：4

共 50 条

[1] Bedaquiline susceptibility test for totally drug-resistant tuberculosis Mycobacterium tuberculosis
Jang, Ji-Chan
Jung, Yong-Gyun
Choi, Jungil
Jung, Hyunju
Ryoo, Sungweon
[J]. JOURNAL OF MICROBIOLOGY, 2017, 55 (06) : 483 - 487
[2] In vitro susceptibility testing and totally drug-resistant tuberculosis
Sotgiu, Giovanni
Spanevello, Antonio
Migliori, Giovanni Battista
[J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42 (01) : 292 - 292
[3] Bedaquiline for the treatment of drug-resistant tuberculosis
Belard, Sabine
Heuvelings, Charlotte C.
Janssen, Saskia
Grobusch, Martin P.
[J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2015, 13 (05) : 535 - 553
[4] Bedaquiline for Multi Drug-Resistant, Including Extensively or PreExtensively Drug-Resistant, Pulmonary Mycobacterium Tuberculosis in Children
Moodliar, R.
Aksenova, V.
Frias, M. V. G.
van de Logt, J.
Rossenu, S.
Birmingham, E.
Kambili, C.
Zhuo, S.
Mao, G.
Lounis, N.
Bakare, N.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
[5] Totally Drug-Resistant Tuberculosis in India
Udwadia, Zarir F.
Amale, Rohit A.
Ajbani, Kanchan K.
Rodrigues, Camilla
[J]. CLINICAL INFECTIOUS DISEASES, 2012, 54 (04) : 579 - U156
[6] Emergence of New Forms of Totally Drug-Resistant Tuberculosis Bacilli Super Extensively Drug-Resistant Tuberculosis or Totally Drug-Resistant Strains in Iran
Velayati, Ali Akbar
Masjedi, Mohammad Reza
Farnia, Parissa
Tabarsi, Payam
Ghanavi, Jalladein
ZiaZarifi, Abol Hassan
Hoffner, Sven Eric
[J]. CHEST, 2009, 136 (02) : 420 - 425
[7] Combating drug-resistant tuberculosis: the unexpected benefits of bedaquiline
Furin, Jennifer
Diacon, Andreas H.
Andries, Koen
[J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2017, 21 (01) : 4 - 5
[8] Bedaquiline and delamanid in combination for treatment of drug-resistant tuberculosis
Mohr, Erika
Ferlazzo, Gabriella
Hewison, Cathy
De Azevedo, Virginia
Isaakidis, Petros
[J]. LANCET INFECTIOUS DISEASES, 2019, 19 (05): : 470 - 470
[9] Bedaquiline: A novel drug to combat multiple drug-resistant tuberculosis
Goel, Divya
[J]. JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2014, 5 (01) : 76 - 78
[10] Editorial: Drug-resistant Mycobacterium tuberculosis
Boshoff, Helena I. M.
Warner, Digby F.
Gold, Ben
[J]. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13

← 1 2 3 4 5 →